October 10, 2012 RESUME NAME: Shuster, Jonathan J. BORN ... · (2/3) (with M. Chang and J Kepner)....

October 10, 2012

RESUME

NAME: Shuster, Jonathan J. BORN: Montreal, P.Q., Canada 1-6-43 CITIZENSHIP: USA MARITAL STATUS: Married, two children EDUCATION: B.Sc. McGill University, Montreal, 1964 (Chemistry) M.Sc. McGill University, Montreal, 1967 (Math-Statistics) Ph.D. McGill University, Montreal, 1969 (Math-Statistics) AWARDS: The National Research Council of Canada Studentship (1968-69) Warner Lambert Research Award (1980) Research Achievement Award (UF) (1990, 1991, 1992,1993) (Only years awarded) University of Florida Research Foundation Professorship: 2000-2002 PROFESSIONAL MEMBERSHIPS: American Statistical Association (Elected Fellow 1992 ) Society for Clinical Trials (1981-) EMPLOYMENT EXPERIENCE: Sir George Williams University: Lecturer, 1966-68 (Math-Statistics) McGill University: Lecturer, 1968-69 (Math) University of Florida: Assistant Professor, 1969-74 (Statistics) Tenured Associate Professor, 1974-80 (Statistics) Professor, 1980 - 2001 (Statistics) Adjunct Professor 2002 Assoc. Chair of Statistics, College of Medicine 2000-2001 Research Professor of Statistics 2003-2005 Research Professor of Epidemiology/Health Policy 2005- McGill University: Visiting Associate Professor, 1976-77 (Math-Statistics) CONSULTING EXPERIENCE IN STATISTICS: VA Hospital, Gainesville, Florida, 1974 - 1994 B&M Chemicals, St. Petersburg, Florida 1974-75 Group Statistician, U. F. Center for Ambulatory Studies, 1975-84 Louisiana State University, Department of Ophthalmology, 1978-83 Affiliate Faculty - Health Services Research - VA Hospital, 1980-82 National Institutes of Health - Special Biostatistical Study Section - 1982-84

J. J. Shuster CONSULTING EXPERIENCE IN STATISTICS: (Continued) National Institutes of Health - Epidemiology and Disease Control Study Section, 1986-90 (Chairman 1989-90) President - Research Assistance Corporation, 1981 - 2009 Florida Association of Pediatric Tumor Programs, 1981 -1993 University of Minnesota, 1989 - 1996 Lederle Laboratories, 1987 - 89 National Institutes of Health, Cancer Clinical Investigation Review Committee, 1991- 1993 Associate Editor, Journal of the American Statistical Association, 1993-1995 Editorial Board, Sequential Analysis 1996- Editorial Board, Blood 1999-2003 National Institutes of Health - Epidemiology of Chronic Disease Study Section, 2003-5 National Institutes of Health –Cardiovascular and Sleep Epidemiology Study Section,2005-2008 Nominated to Peer review group for National Institutes of Health Special emphasis panel For Clinical and Translational Research Awards (2010) General Clinical Research Center (GCRC), University of Florida, Biostatistician 2002- 2009 Shands Clinical Research Unit (Replaced GCRC), Biostatistician 2009- ADMINISTRATIVE EXPERIENCE: Chairman, U. F. Department of Statistics Self-Study Committee, 1970 Undergraduate Coordinator (Statistics), 1971-80 Library Coordinator for Statistics, 1970-71 Chairman, Statistics Sponsored Research Committee, 1974-80 Elected University of Florida Faculty Senate, 1972-75, 1980-82 Member, Institutional Review Board (Human Subjects), University of Florida, 1984-87 and 2006- Director, UF International Center for Childhood Cancer Research 1994-2001 GRANTS AND CONTRACTS: University of Florida Seed Grants, 1973-74, 1980-82 Offshore Power Systems (Jacksonville, Florida), 1973-75 American Cancer Society, 1974-75 National Eye Institute (N.I.H.), 1974-76 Environmental Protection Agency, 1976-80 Severity Indexes 1979-82 (NIH, Co-Investigator) Statistical Office, Pediatric Oncology Group (National Cancer Institute, Co-Principal Investigator, 1980- 93, PI 1993 -2000)

J. J. Shuster GRANTS AND CONTRACTS: (Continued) Research Data Center, Children’s Oncology Group (National Cancer Institute, Director 2000-2001 and Adjunct 2002- POG as a Research Base for Community Cancer Outreach Programs (National Cancer Institute PI 1993 -97 Co-PI 1997-2001) University of Florida General Clinical Research Center-Biostatistician 2002-2009 University of Florida Clinical and Translational Research Institute-Co-Director Research and Data Analysis Design Program 2009- HOBBIES: Duplicate Bridge, Keyboards/Synthesizer/Digital Music Production

BOOKS and BOOK CHAPTERS: Handbook of Sample Sizes for Clinical Trials. Chemical Rubber Company: Boca Raton (1990, 1992). Handbook of Statistics in Clinical Oncology, John Crowley, ed. Marcel Decker, NY, 2

nd edition (2006, Chapter 13)

Textbook of Clinical Trials, D. Machin, S. Day, and S. Green eds.,Wiley Publications, West Sussex, UK (2006, Chapter 5, co-author Dr. S. Murphy) Topics in Biostatistics, Walter Ambrosius, Ed., Humana Press, Totowa, NJ (2007, Chapter 12)

PUBLICATIONS, REFEREED STATISTICS JOURNALS: (N=51) (Relevant to Consulting)

On the Inverse Gaussian Distribution Function. JASA vol. 63, 1968, pp 1514-1516.

A Note on the Borel-Cantelli Problem. Can. Math. Bull. vol. 13, 1970, pp 273-276. Two-way Analysis of Reciprocals (with C. Miura). Biometrika vol. 59, 1972, pp 478-481. A Generalization of the Weak Version of the Glivenko-Cantelli Theorem. Ann. Math.

Statist. vol. 43, 1972, pp 1010-1011. A Simple Method of Teaching the Independence of X and S2. Amer. Statistician vol. 27, 1973, pp 28-29. Comparison of Failure Rates Using Rank Tests (with M. S. Chikkagoudar). JASA vol. 69, 1974, pp 411-413. Optimal Allocation of Observations for Partitioning a Set of Items into Two Control

Groups (with M. Yang). Biometrika vol. 61, 1974, pp 191-193. Exact Tests for Zero Drift Based on First Passage Times in Brownian Motion (with V.

Seshadri). Technometrics vol. 16, 1974, pp 193-195. The Validation of a Petition by a Survey Sample. Comm. in Statistics vol. 5, 1974, pp 291-296. A Distribution-Free Approach to Quantal Response Assays (with M. C. K. Yang). Can.

J. of Statist. vol. 3, 1975, pp 57-70.

J. J. Shuster PUBLICATIONS, REFEREED STATISTICS JOURNALS: (Continued)

Two-way Contingency Tables for Complex Sampling Schemes (with D. Downing).

Biometrika vol. 63, 1976, pp 271-276. Quantal Response Assays by Inverse Regression (with F. H. Dietrich). Comm. in Statist.

vol. 5, 1976, pp 293-305. The Precision of an Estimator Due to Ryan. Comm. in Statist. vol. 5, 1976, pp 867-874. Nonparametric One-Sided Tests in Multivariate Analysis (with J. Boyett). JASA vol. 72,

1977, pp 665-668.

Nonparametric Multiple Comparison Procedures (with J. Boyett). JASA vol. 74, 1979, pp 379-382. Nonparametric Optimality of the Sample Mean and Sample Variance. American

Statistician vol. 36, 1982, pp 176-178.

Interaction Between Prognostic Factors and Treatment (with J. van Eys). Controlled Clinical Trials vol. 4, 1983, pp 209-214.

Are Uniformly Most Powerful Unbiased Tests Really Best? (with S. Suissa). American

Statistician vol. 38, 1984, pp 204-206. Exact Unconditional Sample Sizes for the 2x2 Binomial Trial (with S. Suissa). J. Royal

Statistical Society vol. A148, 1985, pp 317-327.

The Cross-Product Estimator in Matched Case-Control Studies. Biometrika vol. 73, 1986, pp 212-216.

EXACTB and CONF: Exact Unconditional Procedures for Binomial Data. American

Statistician vol. 42, 1988, pp 234. ** A Statistician in a Reverse Drug Sting. American Statistician vol. 45, 1991, pp 123-124

(1/1). The 2X2 Matched Pairs Trial: Exact Unconditional Design and Analysis (with S.

Suissa). Biometrics vol. 47, 1991, pp 361-372 (lead article) (2/2). An Automated Patient Registration and Treatment Randomization System for

Multicenter Clinical Trials (with J.P. Krischer et al), Controlled Clinical Trials vol. 12, 1991, pp 367-377 (7/7).

Parametric vs Non-parametric Methods for Estimating Cure Rates on Censored Survival

Data. (with A. Cantor) Statistics in Medicine vol. 11, 1992, pp 931-937 (2/2). Exact Unconditional Tables for Significance Testing in the 2x2 Multinomial Trial.

Statistics in Medicine vol. 11, 1992, pp 913-922 (1/1).

Fixing the Number of Events in Large Comparative Trials with Low Event Rates: A Binomial Approach. Controlled Clinical Trials vol. 14, 1993, pp. 198-208 (1/1).

PUBLICATIONS, REFEREED STATISTICS JOURNALS: (Continued)

** After 1989, (a/b)=a-th author of a total of b authors

J. J. Shuster Management of Cytogenetic Data in Multi-Center Leukemia Trials. Computer Methods

and Programs in Biomedicine vol. 40, 1993, pp. 269-277 (1/9) Interim Analysis For Randomized Clinical Trials: Simulating The Predictive Distribution

of the Logrank Test Statistic. (with M. Chang). Biometrics, 1994, vol. 50(3), pp. 827-833 (2/2)

Modeling Cure Rates using the Gompertz model with Covariates. Statistics in Medicine ,

1998, vol. 17, pp. 831-839. (With P. Gieser et. al.) (4/5) Publishing clinical trials and dealing with external comparisons. Controlled Clinical

Trials , 1998, vol. 19, 269-270 (1/1) Group sequential designs for phase II trials. Controlled Clinical Trials , 1999, vol. 20,

pp. 353-364 (With M. Chang and J. Kepner) (2/3) Dependence in simulation: A case study from the game of contract bridge.

American Statistician, 2001, vol. 55, pp 306-309. (1/1) Minimax two stage designs with applications to tissue banking case-control studies.

Statistics in Medicine, 2002, vol 21, pp 2479-2493 (1/5) Optimal Two-Stage Designs for Single Arm Phase II Cancer Trials. Journal of

Biopharmaceutical Statistics, 2002, vol. 12, pp 39-51. (1/1)

Sample Sizes based on Exact Unconditional Tests for Phase II Clinical Trials with

Historical Controls. Journal of Biopharmaceutical Statistics, 2004, vol. 14, pp 189-200.

(2/3) (with M. Chang and J Kepner). Design of Group Sequential Trials with Ordinal Categorical Data based on the Mann-

Whitney-Wilcoxon Test. Sequential Analysis (Wald Centennial Issue), 2004, Vol. 23, pp 413-426. (With M Chang and L. Tian) (1/3)

Diagnostics for assumptions in moderate to large simple clinical trials: Do they

really help? Statistics in Medicine, 2005(Aug), vol 24, pp 2431-2438 (1/1) (Lead article)

A two-player coin game paradox in the classroom. American Statistician, 2006(Feb),

vol 60, pp 68-70. (1/1) Interrupted time series was accurate in showing improvement in mediaction errors.

Journal of Clinical Epidemiology, 2006 Sep;59(9):957-963 (With A. Winterstein) (1/2)

Design alternatives for four team double elimination tournaments. The Mathematical

Scientist, 2006, Dec; 31, 95-106. (with S. Wu and A. Sun) (1/3) Fixed vs. random effects meta-analysis in rare event studies: The Rosiglitazone link with myocardial infarction and cardiac death. Statistics in Medicine, 2007 Oct; 26: 4375-4385. (With L. Jones and D. Salmon) (1/3) Second guessing clinical trial designs. Sequential Analysis. 2008, January; 27:2-20

(With M Chang) (1/2) (Respones to Discussants pp 50-57)

J. J. Shuster PUBLICATIONS, REFEREED STATISTICS JOURNALS: (Continued)

How conservative is Fisher's exact test? A quantitative evaluation of the two-sample

comparative binomial trial. Statistics in Medicine, 2008; 27: 3598-3611. (With G Crans) (2/2)

Applying Hodges-Lehmann Scale Parameter Estimates to Hospital Discharge Times. In

Press Clinical Trials, 2008 Dec; vol 5, pp 631-634. (With D. Theriaque and B. Ilfeld) (1/3)

Student T-tests for potentially abnormal data. Statistics in Medicine, 2009; 28: 2170-

2184. (1/1) Discussion on “A Hybrid Selection and Testing Pocedure with Curtailment for

Comparitive Clinical Trials” Sequential Analysis. 2009; 28(1):34-37 (1/1)

Empirical vs natural weighting in random effects meta-analysis. Statistics in

Medicine, 2010; 29 (May): 1259-1265.

Reply to Discussion of “Empirical vs. natural weighting in random effects meta- analysis” Statistics in Medicine, 2010; 29: 1272-1281. (1/4)

Review: Cochrane handbook for systematic reviews for interventions. Research Synthesis

Methods, 2011; 2: 126-130. Peer reviewed book review with some new methodology.

(1/1)

Improved Two-Stage Tests for Stratified Phase II Cancer Clinical Trials, Statistics in

Medicine, 2011. In Press with M.Chang and W. Hou (2/3).

J. J. Shuster

JOINT PUBLICATIONS, REFEREED MEDICAL JOURNALS:(N=281)

(Relevant to Collaborative research) If I Can’t Measure It, What Do I Do With It? (with H. Kaufman). Investigative

Ophthalmology vol. 13, 1974, pp 412-413. Statistical Review Process: Recommended Procedures for Biomedical Research

Articles. J. Amer. Med. Assoc. vol. 235, 1976, pp 534-535. Joint Contracture - Common Manifestation of Childhood Diabetes Mellitus (with A.

Grgic, A. Rosenbloom, F. Weber, B. Giordano, and J. Majone). J. Pediatrics vol. 88, 1976, pp 584-588.

Human Leukocyte Interferon for the Prevention of Recurrences of Herpetic Keratitis

(with H. Kaufman, R. Meyer, P. Laibson, S. Waltman, and A. Nesburn). J. Infectious Diseases vol. 133, 1976, pp A165-168.

Neuropsychological Effects of Continuous Oxygen Therapy in the Aged (with H. Krop,

A. Block, E. Cohen, and R. Croucher). Chest vol. 72, 1977, pp 737-743. Occupational Therapy Sequential Client Care Recording System: A Comparative Study

(with L. Llorens). Amer. J. Occupational Therapy vol. 31, 1977, ppp 367-371.

Susceptibility of the Anaerobic Bacteria, Group D Streptococci, Enterobacteriaceae, and Pseudomonas to Semisynthetic Penicillins: Carbenicillin, Piperacillin, and Ticaricillin (with G. Monif, P. Clark and H. Baer). Antimicrobial Agents and Chemotherapy vol. 14, 1978, pp 643-649.

The Effectiveness of Laboratory vs. Written Examinations in an Anatomy Course (with

A. Gill and N. Marmo). Amer. J. Occupational Therapy vol. 32, 1978, pp 26-30.

Comparison of Three Positions for Evaluation of the Asymmetrical Tonic Nect Refex (with K. Sieg). Amer. J. Occupational Therapy vol. 33, 1979, pp 311-316.

An Evaluation of the Accuracy of Community-Based Perimetry (with J. Trobe, P. Acosta,

and J. Krischer). Amer. J. Ophthalmology vol. 90, 1980, pp 654-660. Statistical Analysis of the Rate of Recurrence of Herpes Virus Ocular Epithelial Disease

(with H. Kaufman and A. Nesburn). Amer. J. Ophthalmology vol. 91, 1981, pp 328-331. Effects of Nutrition on Length of Stay and Survival for Burned Patients (with H.

Bingham, J. Krischer and I. Engelman). Burns vol. 7, 1981, pp 252-257. A Testing of Principles for Severity Index Construction With Application to Burn

Injuries (with J. Krischer, H. Bingham, and R. Melker). Burns vol. 8, 1981, pp 1-5.

Diagnostic Strategies in the Management of Unexplained Visual Loss: A Cost Benefit

Analysis (with P. Acosta, J. Trobe and J. Krischer). J. Society for Medical Decision Making vol. 1, 1981, pp 125-144.

CNS Prophylaxis in Acute Lymphoblastic Leukemia - Comparison of Two Methods

(with D. Komp, et al). Cancer vol. 50, 1982, pp 1031-1036. Water Hardness and Urinary Stone Disease (with B. Finlayson, R. Scheaffer, et al).

Journal of Urology vol. 128, 1982, pp 422-425.

J. J. Shuster

J. J. Shuster JOINT PUBLICATIONS, REFEREED MEDICAL JOURNALS: (Continued)

HLA and Ophthalmic Disease Associations: A Critical Review and Improved Methods

for Statistical Analysis (with C. E. Margo and J. D. Trobe). ACTA Ophthalmologica vol. 60, 1982, pp 533-546.

Phase II Study of Four Drug Chemotherapy in Metastatic Neuroblastoma: A Pediatric

Oncology Group Study (with V. Land, et al). Cancer Treatment Reports vol. 67, 1983, pp 187-188.

Hospital or Population Controls: A Discussion (with B. Cook). J. Chronic Diseases vol. 36, 1983, pp 315-316. High-Dose Methotrexate as Part of Remission Maintenance Therapy for Childhood Acute

Lymphocytic Leukemia: A Pediatric Oncology Group Pilot Study (with L. Frankel, et al). J. of Clinical Oncology vol. 1, 1983, pp 804-809.

Economic Impact of Urinary Stone Disease (with R. Scheaffer). Urology vol. 24, 1984,

pp 327-331. A Well Woman’s Health Maintenance Study Comparing Physical Fitness and Group

Systems (with A. Gill, et al). Occupational Therapy Journal of Research vol. 4, 1984, pp 286-308.

Ethical Issues in Cooperative Cancer Therapy Trials From a Statistical Viewpoint.

I. A General Overview (with J. Krischer and J. Boyett). Amer. J. of Pediatric Hematology/Oncology vol. 7, 1985, pp 57-63.

Ethical Issues in Cooperative Cancer Therapy Trials From a Statistical Viewpoint.

II. Specific Issues (with J. Krischer and J. Boyett). Amer. J. of Pediatric Hematology/Oncology vol. 7, 1985, pp 64-70.

Primary Liquid Intake and Urinary Stone Disease (with B. Finlayson and R. Scheaffer, et

al). J. Chronic Dis. vol. 38, 1985, pp 907-914.

An Analysis of the Presence of Fc Receptors on Bone Marrow Lymphoblasts in Acute Lymphoblastic Leukemia (with G. B. Humphrey, et al). Cancer vol. 56, 1985,

pp 1995-2000. The Influence of Skeletal Implants on Incidence of Infection (with W. Petty, et al). J. of

Bone and Joint Surgery vol. 67A, 1985, pp 1236-1244. The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients With

Osteosarcoma of the Extremity (with M. Link, et al). New Eng. J. Med vol. 314, 1986, pp 1600-1602.

Effect of Trimethoprim/Sulfamethoxazole Prophylaxis on Outcome of Childhood

Lymphocytic Leukemia, A Pediatric Oncology Group Study (with J. van Eys, et al). Cancer vol. 59, 1987, pp 19-23.

A Morphologic Study of Childhood Lymphoma of the Small Noncleaved Type: The

Pediatric Oncology Group Experience (with D. R. Kelly, et al). Cancer vol. 59, 1987, pp 1132-1137.

J. J. Shuster JOINT PUBLICATIONS, REFEREED MEDICAL JOURNALS: (Continued)

A Morphologic Study of Childhood Lymphoma of the Diffuse “Histiocytic” Type: The

Pediatric Oncology Group Experience (with B. N. Nathwani, et al). Cancer vol. 59, 1987, pp 1137-1142. A Morphologic Study of Childhood Lymphoma of the Lymphoblastic Type: The

Pediatric Oncology Group Experience (with R. C. Griffith, et al). Cancer vol. 59, 1987, pp 1126-1131.

Lymphoblastic Lymphoma in Children: A Randomized Trial Comparing LSA2L2 With

the A-COP+ Therapeutic Regime (with E. Hvizdala, et al). J. Clin. Oncol vol. 6, 1987, pp 26-33.

Diabetologists’ Judgments of Diabetic Control: Reliability and Mathematical Simulation

(with M. Spevack, et al). Diabetes Care vol. 10, 1987, pp 217-224. Prevention of Infection After Total Joint Replacement (with W. Petty, et al). J. Bone and

Joint Surgery vol. 70-A, 1988, pp 536-539. Localized Neuroblastoma Treated by Surgery: A Pediatric Oncology Group Study (with

R. Nitschke, et al). J. Clinical Oncology vol. 6, 1988, pp 1271-1279. Preclinical Training in Bronchoscopic Diagnosis of Cancer (with J. Rayl and J. Pitman).

Chest vol. 93, 1988, pp 824-827. Clinical Features and Outcome in Childhood T-Cell Leukemia-Lymphoma According to

Stage of Thymocyte Differentiation (with W. Crist, et al). Blood vol. 72, 1989, pp 1891-1897. A Comparison of Two Regimens for High-Risk Acute Lymphocytic Leukemia in

Childhood. A Pediatric Oncology Group Study (with J. van Eys, et al). Cancer vol. 63, 1989, pp 23-29.

Treatment Intensity and Outcome for Children with Acute Lymphocytic Leukemia of

Standard Risk. A Pediatric Oncology Group Study (with J. van Eys, et al). Cancer vol. 63, 1989, pp 1466-1471.

Intermediate Dose Intravenous Methotrexate and Mercaptopurine Therapy for Non-T,

Non-B Acute Lymphocytic Leukemia of Childhood: A Pediatric Oncology Group Study (with B. Camitta, et al). Journal of Clinical Oncology vol. 7, 1989, 1539-1544.

The Impact of Stage and Treatment Modality on the Likelihood of Second Malignancies

and Hematopoietic Disorders in Hodgkin’s Disease (with N. Mendenhall, et al). Radiotherapy Oncology vol. 14, 1989, pp 219-229.

Diffuse Small Noncleaved Cell Lymphoma in Children, Burkitt’s Versus Non-Burkitt’s

Types. Results from the Pediatric Oncology Group and St. Jude Children’s Research Hospital (with R. E. Hutchinson, et al). Cancer vol. 64, 1989,

pp 23-28. ** Clinical and Biological Heterogeneity of Childhood B-Cell Acute Lymphocytic

Leukemia: Implications for Clinical Trials (with M. Sullivan, et al.). Leukemia vol. 4, 1990, pp 6-11 (9/10).

** After 1989, (a/b)=a-th author of a total of b authors.

J. J. Shuster JOINT PUBLICATIONS, REFEREED MEDICAL JOURNALS: (Continued)**

Prognostic Factors in Childhood T-Cell Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study (with J. Falletta, et al). Blood vol. 75, 1990, pp 166-173. [Hematology Digest published abstract as “outstanding in its field”.] (1/8).

The Effect of Local Extent of the Tumor on Prognosis in Osteosarcoma (with S. Spanier,

R.A. Vander Griend). The Journal of Bone and Joint Surgery vol. 72A, 1990, pp 643-653 (2/3). Prospective Randomized Comparison of 5-Fluorouricil versus 5-Flurouricil and High

Dose Leucovorin Calcium for the Treatment of Advanced Colorectal Cancer in Patients Previously Unexposed to Chemotherapy (with J. Doroshow, et al). Journal of Clinical Oncology vol. 8, 1990, pp 491-501 (12/13).

Philadelphia Chromosome Positive Childhood Acute Lymphoblastic Leukemia: Clinical

and Cytogenetic Characteristics and Treatment Outcome. A Pediatric Oncology Group Study (with W. Crist, et al). Blood vol. 76, 1990, pp 489-494 (3/14).

Poor Prognosis of Children with Pre-B Acute Lymphoblastic Leukemia is Associated

with the t (1;19) (q 23; p 13). A Pediatric Oncology Group Study (with W. Crist, et al). Blood vol. 76, 1990, pp 117-122 (3/11).

Results of Treatment of Childhood Localized Non-Hodgkin’s Lymphoma with

Combination Chemotherapy with or without Radiotherapy (with M. Link, et al). New England Journal of Medicine vol. 322, 1990, pp 1169-1174(lead article) (5/6).

Clinical Presentation, Karyotypic Characterization, and Treatment Outcome of Childhood

Acute Lymphoblastic Leukemia With a Near-Haploid or Hypodiploid <45 Line (with C. Pui, et al). Blood vol. 75, 1990, pp 1170-1177 (6/11).

Accumulation of Methotrexate and Methotrexate Polyglutamates in Lymphoblasts at

Diagnosis of Childhood Acute Lymphoblastic Leukemia: A Pilot Prognostic Factor Analysis (with M. Whitehead, et al). Blood vol. 76, 1990, pp 44-49 (4/6).

Prognostic Significance of CD34 Expression in Childhood B-Precursor Acute

Lymphocytic Leukemia: A Pediatric Oncology Group Study (with M. Borowitz, et al). J. Clinical Oncology vol. 8, 1990, pp 1389-1398 (2/9).

Near-Triploid and Near-Tetraploid Acute Lymphoblastic Leukemia of Childhood (with

C. Pui, et al). Blood vol. 76, 1990, pp 590-596 (4/13). Adjuvant Chemotherapy of High Grade Osteosarcoma of the Extremity: Updated Results

of the Multi-Institutional Osteosarcoma Study (with M. Link et al). Clinical Orthopaedics vol. 270, 1991, pp 8-14 (8/8).

Remission Induction and Continuation Therapy in Children with their First Relapse of

Acute Lymphoid Leukemia (with S. Culbert, et al). Cancer vol. 67, 1991, pp 37-42 (2/9).

Clinical Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic

Leukemia With the t(4;11) (q21;23): A Collaborative Study of 40 Cases (with C. Pui, et al). Blood vol. 77, 1991, pp 440-447 (5/12).

J. J. Shuster

JOINT PUBLICATIONS, REFEREED MEDICAL JOURNALS: (Continued)**

A Pilot Study of Intermediate-Dose Methotrexate and Cytosine Arabinoside, “Spread-Out” or “Up-Front,” in Continuation Therapy for Childhood Non-T, Non-B Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study (with R. Krance, et al). Cancer vol. 67, 1991, pp 550-556 (6/9).

High-Dose Chemoradiotherapy Supported by Marrow Infusions for Advanced

Neuroblastoma: A Pediatric Oncology Group Study (with J. Graham-Pole, et al). Journal of Clinical Oncology vol. 9, 1991, pp 152-158 (10/13).

Philadelphia Chromosome and Monosomy 7 in Childhood Acute Lymphoblastic

Leukemia: A Pediatric Oncology Group Study (with C. Russo, et al). Blood vol. 77, 1991, pp 1050-1056 (8/12).

Laboratory Correlates and Prognostic Significance of Granular Acute Lymphoblastic

Leukemia in Children: A Pediatric Oncology Group Study (with Cerezo, et al). American Journal of Clinical Pathology vol. 95, 1991, pp 526-531 (2/8).

Clinical Relevance of Tumor Cell Ploidy and N-myc Gene Amplification in Childhood

Neuroblastoma: A Pediatric Oncology Group Study (with Look, et al). Journal of Clinical Oncology vol. 9, 1991, pp 581-591 (3/8).

Changing Pattern of Pulmonary Metastases with Adjuvant Chemotherapy in Patients with

Osteosarcoma: Results from the Multi-institutional Osteosarcoma Study (with Goorin, et al). Journal of Clinical Oncology vol. 9, 1991, pp 600-605 (2/6).

Radiotherapy Improves the Outlook for Patients Older than One Year with POG Stage C

Neuroblastoma (with R. Castleberry, et al). Journal of Clinical Oncology vol. 9, 1991, pp 789-795 (3/9).

Post-operative Treatment of Non-metastatic Visible Residual Neuroblastoma: A

Pediatric Oncology Group Study (with R. Nitschke, et al). Journal of Clinical Oncology vol. 9, 1991, pp 1181-1188 (5/8).

The Prognostic Significance of Autologous Bone Marrow Transplant in Advanced

Neuroblastoma (with McWilliams, et al). Journal of Clinical Oncology, vol. 9, 1991, pp 1045-1049 (1/9).

Non-lymphoblastic Lymphoma in Children: Histology and Stage-Related Response to

Therapy: A Pediatric Oncology Group Study (with Hvizdala, et al). Journal of Clinical Oncology vol. 9, 1991, pp 1189-1195 (6/8).

Clinical Characteristics and Treatment Outcome of Children with Acute Lymphocytic

Leukemia and Down’s Syndrome: A Pediatric Oncology Group Study (with Ragab, et al). Cancer vol. 67, 1991, pp 1057-1063 (2/9).

High-Dose Cyclophosphamide–High-Dose Methotrexate with Coordinated Intrathecal

Therapy for Advanced Non-Lymphoblastic Lymphoma of Childhood: Results of A Pediatric Oncology Group Study (with M. Sullivan, et al). American Journal of Pediatric Hematology/ Oncology vol. 13(3), 1991, pp 288-295 (7/10).



Lower Incidence of Meningeal Leukemia When Prednisone is Replaced by

Dexamethasone in the Treatment of Acute Lymphocytic Leukemia (with A. Freeman, et al). Medical and Pediatric Oncology vol. 19, 1991, pp 269-275 (3/27).

A Population Based Study of Neuroblastoma incidence, survival, and mortality in North

America (with M. Bernstein, W. Woods, et al). Journal of Clinical Oncology vol. 10, 1992, pp 323-329 (6/14).

Recommendations for Modification of Terminology of Neuroblastic Tumors and

Prognostic Significance of Shimada Classification: A Clinicopathologic Study of 213 Cases from the Pediatric Oncology Group. (with V. Joshi, et al). Cancer

vol. 69, 1992, pp 2183-2196 (6/9). Age-Linked Prognostic Categorization Based on A New Histologic Grading System of

Neuroblastomas: A Clinicopathologic Study of 211 Cases from the Pediatric Oncology Group (with V. Joshi, et al). Cancer vol. 69, 1992, pp 2197-2211 (6/13).

Progress Against Childhood Cancer: The Pediatric Oncology Group Experience (with

Vietti, et al). Pediatrics vol. 89, 1992, pp 597-600 (2/26). Ploidy of Lymphoblasts Is the Strongest Predictor of Treatment Outcome in B-Progenitor

Cell Acute Lymphoblastic Leukemia of Childhood: A Pediatric Oncology Group Study (with R. Trueworthy, et al). Journal of Clinical Oncology vol. 10, 1992, pp 606-613 (2/14).

Isochromosomes in Childhood Acute Lymphoblastic Leukemia: A Collaborative Study of 83 Cases (with Pui, et al). Blood vol. 79, 1992, pp 2384-2391 (6/12).

Treatment of Occult or Late Overt Testicular Relapse in Children with Acute

Lymphoblastic Leukemia: A Pediatric Oncology Group Study (with M. Wofford, et al). Journal of Clinical Oncology vol. 10, 1992, pp 624-630 (3/11).

Trisomy of Leukemic Cell Chromosomes 4 and 10 Identifies Children with B-Progenitor

Cell Acute Lymphoblastic Leukemia with a very Low Risk of Treatment Failure: A Pediatric Oncology Group Study (with M. Harris, et al). Blood vol. 79, 1992,

pp 3316-3324 (2/10). Accumulation of High Levels of Methotrexate Polyglutamates in Lymphoblasts from

Children with Hyperdiploid (>50 Chromosomes) B-Lineage Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study (with M. Whitehead et al). Blood vol. 80, 1992, pp 1316-1323 (6/14).

Different Patterns of Relapse Associated with Three Intensive Treatment Regimens for

Pediatric E-Rosette Positive T-Cell Leukemia: A Pediatric Oncology Group Study (with J. Falletta et al). Leukemia vol. 6, 1992, pp 541-546 (2/9).


J. J. Shuster


The Non-Random dic(9;12) Translocation in Acute Lymphoblastic Leukemia is

Associated with B-Progenitor Phenotype and an Excellent Prognosis (with H. Mahmoud et al). Leukemia vol. 6, 1992, pp 703-707 (5/10).

Soft Drink Consumption and Urinary Stone Recurrence: A Randomized Prevention Trial

(with A. Jenkins et al). Journal of Clinical Epidemiology vol. 45, 1992, pp 911-916. [Clinical Digest Award: Outstanding in its field] (1/10).

Serum Lactate Dehydrogenase in Childhood Neuroblastoma: A Pediatric Oncology

Group Recursive Partitioning Study (with McWilliams, et al). Am J of Clinical Oncology vol. 15, 1992, pp 295-303 (1/11).

Childhood Malignant Non-Hodgkin Lymphomas of Uncommon Histology (with R.

Ribeiro et al). Leukemia vol. 6, 1992, pp 761-765 (4/11). Current Results of Studies of Immunophenotype-, Age- and Leukocyte-Based Therapy

for Children with Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study (with W. Crist, et al). Leukemia vol. 6, 1992, Suppl 2, pp 162-166 (2/14).

Infants with Neuroblastoma and Regional Lymph Node Metastases have a Favorable

Outlook after limited Post-Operative Chemotherapy. A Pediatric Oncology Group Study (with R. Castleberry et al). Journal of Clinical Oncology vol. 10, 1992, pp 1299-1304 (2/9).

Morphologic, Immunologic and Cytogenetic Studies in Children with Acute

Lymphoblastic Leukemia at Diagnosis and Relapse: A Pediatric Oncology Group Study (with T. Abshire, et al). Leukemia vol. 6, 1992, pp 357-362 (4/11).

Screening for Neuroblastoma in North America: Two Year Results From the Quebec

Project (with W. Woods, et al). Am J. Hem. Onc. vol. 14(4), 1992, pp 312-319 (11/12).

Red Blood Cell Methotrexate and Folate Levels in Children with Acute Lymphoblastic

Leukemia Undergoing Therapy: A Pediatric Oncology Group Pilot Study (with M. Graham, et al). Cancer Chemotherapy and Pharmacology vol. 3, 1992,

pp 217-222 (2/8). Correlation Between Morphologic and Other Prognostic Markers of Neuroblastoma: A

Study of Histologic Grade, DNA Index, N-MYC Gene Copy Number and Lactic

Dehydrogenase in Cases from the Pediatric Oncology Group. American Society

of Clinica Oncology, Cancer, vol. 71, 1993, pp 3173-3181 (5/11) (with V. Joshi et

al) Secondary Acute Myeloid Leukemia in Children with Acute Lymphoblastic Leukemia

Treated with an Etoposide (with N. Winick, et al). J. Clinical Oncology vol. 11(2), 1993, pp 271-278 (3/9).

Treatment of Central Nervous Relapse in Children with Acute Lymphoblastic Leukemia:

A Pediatric Oncology Group Study (with N. Winick, et al). J. Clinical Oncology vol. 11, 1993, pp 209-217 (3/7).


J. J. Shuster


Use of Clinical and Laboratory Features to Define Prognostic Subgroups in B-Precursor Acute Lymphoblastic Leukemia: Experiences of the Pediatric Oncology Group. (with M. Borowitz, et al). Recent Results in Cancer Research vol. 131, 1993, pp 257-267 (3/9).

Thoracic Neuroblastoma: A Pediatric Oncology Group Study (with G. Adams et al).

Journal of Pediatric Surgery vol. 28, 1993, pp 372-378 (4/10). Clinical Features and Outcome of T-Cell Acute Lymphoblastic Leukemia in Childhood

With Respect to Alterations at the TAL1 Locus. A Pediatric Oncology Group Study (with B. Bash, et al). Blood vol. 81, 1993, pp 2110-2117 (3/9).

Treatment of Late Bone Marrow Relapse in Children with Acute Lymphoblastic

Leukemia: A Pediatric Oncology Group Study (with D. Sadowitz, et al). Blood vol. 8, 1993 pp 602-609 (3/6).

Extended Triple Intrathecal Chemotherapy Trial for Prevention of Central Nervous

System Relapse in Good and Poor Patients with B-Progenitor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study (with J. Pullen, et al). Journal of Clinical Oncology vol. 11, 1993, pp 839-849 (3/12).

Intensive Alternating Drug Pairs for Treatment of High Risk Acute Lymphoblastic

Leukemia: A Pediatric Oncology Group Pilot Study (with S. Lauer et al). Cancer vol. 71, 1993, pp 2854-2861 (5/13).

Immunophenotypes and Karyotypes of Leukemic Cells in Children with Down Syndrome

and Acute Lymphoblastic Leukemia (with C. Pui et al). Journal of Clinical Oncology vol. 11, 1993, pp 1361-1367 (8/12).

Predictability of the t(1;19) (q23; p13) from Surface Antigen Phenotype. Implications for

Screening Cases of Childhood ALL for Molecular Analysis. A Pediatric Oncology Group Study (with M. Borowitz et al). Blood vol. 82, 1993, pp 1086-1091 (4/7).

Transitional Pre-B-Cell Acute Lymphoblastic Leukemia of Childhood Associated with

Favorable Prognostic Clinical Features and an Excellent Outcome. A Pediatric Oncology Group Study. Leukemia vol. 7, 1993, pp 2064-1068 (3/11).

High Glucocorticoid Receptor Content of Leukemic Blasts is a Favorable Prognostic

Factor in Childhood Acute Lymphoblastic Leukemia. (with G. Kato et al). Blood vol. 82, 1993, pp 2304-2309 (4/9).

Trisomy 21 in Childhood Acute Lymphoblastic Leukemia: A Pediatric Oncology Group

Study. Blood, vol. 82, 1993, pp 3098-3102. (with M. Watson et al) (3/8). Prognostic Features of Ewing’s Sarcoma on Plan Radiograph and CT Scan After Initial

Treatment. Cancer, vol. 72, 1993, pp 2503-2510 (with W. Reinus et al) (4/5) The Pediatric Oncology Group Experience with the International Staging System (with R.

Castleberry et al). Journal of Clinical Oncology, vol. 12, 1994, pp 2378-2381(2/3)


J. J. Shuster


Systemization of Primary Histopatholoic and Fine-Needle Aspiration Cytologic Features

and Description of Unusual Histopathologic Features of Neuroblastic Tumors: A Report From the Pediatric Oncology Group (with V. Joshi et al) Hum Pathol 1993 May; 24(5): pp. 493-504 (4/9).

Saturable Pharmacokinietcs and Paclitaxcel (Taxol) Pharmacodynamics in Children With

Solid Tumors (with D. Sonnichsen et al). Journal of Clinical Oncology, 1994; 12(3): pp 532-538 (4/5).

Comparison of Two Schedules of Intermediate Dose Methotrexate and Cytarabine

Consolidation Therapy for Childhood B-Precursor Cell Acute Lymphoblastic Leukemia: A POG Study (with Vita Land et al) Journal Clinical Oncology, 12(9): 1939-1945, 1994 (2/8).

Intensive Intravenous Methotrexate and Mercaptopurine Treatment of Higher Risk Non-

T, Non-B Acute Lymphocytic Leukemia: A Pediatric Oncology Group Study. (with B. Camitta et al) J. Clinical Oncology 1994, 12(7), pp. 1383-1389 (4/9)

HLA-Identical Sibling Bone Marrow Transplants vs. Chemotherapy For Children With

Acute Lymphoblastic Leukemia in Second Remission. (with A. Barrett et al). New England Journal of Medicine 1994, 331, pp. 1253-1258 (10/12)

Prognostic Features of Ewing’s Sarcoma On Radionuclide Bone Scan After Initial

Treatment. (with W. Reinus et al). International Journal of Radiology, 1994, 19(12), 1-6 (4/5).

Cyclophosphamide/Doxorubicin Vs. Cisplatin/Teniposide In The Treatment Of Children

Older Than 12 Months Of Age With Disseminated Neuroblastoma: A Pediatric

Oncology Group Randomized Phase II Study. Med Pediatr Oncol

1995;Mar;24(3):176-80.With N McWilliams and others (7/9)

Screening For Neuroblastoma (NB) In North America: The Quebec Project. Prog Clin

Biol Res 1994;385:377-82. (With W Woods et al) (10/10)

Presenting Characteristics Of Trisomy 8 As The Primary Cytogenetic Abnormality

Associated With Childhood Acute Lymphoblastic Leukemia. A Pediatric

Oncology Group (POG) Study (8600/8493).Cancer Genet Cytogenet 1994 Jul

1;75(1):6-10 (With M Pettenati et al) (4/8)

Frequency And Prognostic Significance Of HRX Rearrangements In Infant Acute

Lymphoblastic Leukemia: A Pediatric Oncology Group Study. Blood 1994 Jul

15;84(2):570-3. With J Rubnitz et al (3/8)

Results of Pediatric Oncology Group Protocol 8104 for Infants with Stages D and DS

Neuroblastoma. J. Pediatric Hematology/Oncology, vol. 17, pp. 254-259, 1995.

With D. Strother et. al. (2/9)


J. J. Shuster


Leukemic Cell Growth In SCID Mice As A Predictor Of Relapse In High-Risk B-Lineage Acute Lymphoblastic Leukemia. Blood, vol. 85, pp. 873-878, 1995. (with F. Uckun et al) (4/11)

Significance of Chromosome 1p Loss of Heterozygosity in Neuroblastoma. Cancer

Research, vol. 55 (20), pp 4664-4669, 1995 (with J. Maris et al) (6/8)

B-Cell Lineage Confers Favorable Outcome Among Children And Adolescents With

Large Cell Lymphoma: A Pediatric Oncology Group Study. Journal of Clinical

Oncology vol. 13 (8), pp 2023-2032, 1995 (with R. Hutchinson) (3/6)

Repetitive Low Dose Oral Methotrexate and Intravenous Mercaptopurine Treatment for

Patients with Lower Risk B-Lineage Acute Lymphoblastic Leukemia. A

Pediatric Oncology Group Study. Cancer vol 15, pp 2623-2631, 1995. With D

Mahoney et. al. (4/9) B-Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Oncology , Vol 14, No

10,pp 2803-2811,1996 . (with N. Winick et al) (2/8). The Role of Autologous Bone Marrow Transplantation in Advanced Neuroblastoma.

Journal of Clinical Oncology, vol. 14, no. 9, pp 2413-2414, 1996 (1/1). High Incidence Of Potential P53 Inactivation In Poor Outcome Childhood Lymphoblastic

Leukemia At Diagnosis. Blood, vol. 87, pp 1155-1161, 1996 (with D. Marks et al) (5/8)

Improved Survival For Children With B-Cell Acute Lymphoblastic Leukemia And Stage

IV Small Noncleaved Cell: A Pediatric Oncology Group Study (8617). Journal of Clinical Oncology, vol. 14, pp 1252-1261, 1996 (with P. Bowman et al) (2/9)

Changes In Red Blood Cell Methotrexate Pharmacology And Their Impact On Outcome

When Cytarabinee Is Infused With Methotrexate In The Treatment Of Acute Lymphocytic Leukemia In Children. A Pediatric Oncology Group Study. Clinical Cancer Research, vol. 2, pp 331-337, 1996 (with M. Graham et al) (2/13)

Comparison Of Fluorescence In Situ Hybridization, Cytogenetic Analysis And DNA

Index Analysis To Detect Chromosome 4 And 10 Aneuploidy In Pediatric Acute Lymphoblastic Leukemia. A Pediatric Oncology Group Study. American Journal of Pediatric Hematology/Oncology, vol. 18 (2), 113-121, 1996 (with P. Martin et al) (6/9)

Uniform Approach To Risk Classification And Treatment Assignment For Children With

Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, vol. 14, pp. 18-24, 1996. (with M. Smith et al) (16/21)


J. J. Shuster


High-Dose Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue

For Recurrent/Progressive Malignant Brain Tumors in Children; a Pilot Pediatric

Oncology Group Study. Journal of Clinical Oncology, vol. 14 (2), pp 382-388,

1996 (with D. Mahoney et al) (9/10)

Modified Histologic Grading of Neuroblastomas by Replacement of Mitotic Rate With

Mitosis Karyorrhexis Index. A Clinicopathologic Study of 223 Cases From the

Pediatric Oncology Group. Cancer, vol. 77, pp 1582-1588, 1996 (with V. Joshi et

al) (5/6)

Meta Analysis and Prospective Meta Analysis in Childhood Leukemia Clinical Research.

Annals of Oncology, vol. 7, pp 1009-1014, 1996 (with P. Gieser) (1/2)

Population-based Study of the Usefulness of Screening for Neuroblastoma. The Lancet,

vol. 348, pp. 1682-1687, 1996. With W. Woods et al (9/14) A Therapeutic Trial for Infant Acute Lymphoblastic Leukemia: The Pediatric Oncology

Group Experience. American Journal of Pediatric Hematology/Oncology. Vol 19, pp. 35-42, 1997. With L. Frankel et al (3/10)

Use of an anti-ALK antibody in the characterization of Anaplastic Large Cell Lymphoma

of Childhood. Annals of Oncology 8, pp. S37-S42, 1997. With R Hutchison et al (3/13)

Case-Control Study Suggests a Favorable Impact of TEL Rearrangement in Patients with

B-Lineage Acute Lymphoblastic Leukemia Treated with Antimetabolite-Based Therapy: A Pediatric Oncology Group Study. Blood, 89, pp 1143-1146,1997. With J. Rubnitz et al. (2/10)

Prognostic Significance of Fluorescence Intensity of Surface Marker Expression in

Childhood B-Precursor Acute Lymphoblastic Leukemia. A Pediatric Oncology Group Study. Blood, vol. 89, pp 3960-3966, 1997. With M. Borowitz et al. (2/9)

Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. J. Clinical Oncology vol. 15, pp. 1158-1162, 1997. (With D Marks et. al.) (5/9)

The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J

Cancer 1997 Oct;33(12):2113-6. With R Castleberry et. al. (26/26)

Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable

advanced stage disease in older children. Eur J Cancer 1997 Oct;33(12):2106-12.

With W. Woods et. al. (8/15)


J. J. Shuster


Pediatric Phase II Cancer Chemotherapy Trials. American Journal of Pediatric

Hematology/Oncology, Vol. 19, pp 187-191, 1997 With S. Weitman et. al. (4/9) Fractionated cyclophosphamide and back to back high dose methotrexate

and cytosine arabnoside improves outcome in patients with stage III high grade small non-cleaved cell lymphoma (SNCCL): a randomized trial of the Pediatric Oncology Group. Medical and Pediatric Hematology/Oncology, vol. 29, pp 526-533,1997. With M Brecher et. al. (7/8) Treatment of children and young adults with early stage Non-Hodgkin’s Lymphoma New England Journal of Medicine, Vol 337, pp 1259-1266, 1997. with M. Link et. al (2/8) E2A-PBX1 chimeric transcript states at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemia with a t(1;19)(q23;p13): a Pediatric Oncology Group Study. Blood, Vol. 91, pp 1021- 1028, 1998, with S. Hunger et. al. (9/11) A randomized trial of r-metHuG-CSH in an intensive treatment for T-Cell Leukemia and advanced stage Lymphoblastic Lymphoma of Childhood. A Pediatric Oncology Group Pilot Study. Journal of Clinical Oncology Vol. 16, pp. 522-26, 1998 with J Laver et. al. (7/7) Intensive alternating drug pairs for treatment of infant acute lymphoblastic leukemia. A Pediatric Oncology Group Pilot Study. Journal of Pediatric Hematology/Oncology Vol. 20, pp. 229-233, 1998 with S Lauer et. al. (6/11) Intermediate dose intravenous methotrexate with intravenous mercaptopurine is superior to low dose oral methotrexate with intravenous mercaptopurine for children with lower risk B-Lineage acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Journal of Clinical Oncology, Vol. 16, pp. 246-254, 1998. (with D. Mahoney et al (3/6) Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood acute lymphoblastic leukemia. Clinical Cancer Research, Vol. 4, pp 183-188, 1998, ( with M. Whitehead et. al. ) (6/15) Immature teratomas in children: Pathological considerations. American Journal of Surgical Pathology Vol. 22, pp. 1115-1124, 1998 (With S. Heifetz et. al. (4/7) Accumulation of Methotrexate Polyglutimates, Ploidy, and Trisomies of both Chromosomes 4 and 10 in Lymphoblasts from Children with B-Progentitor Cell Acute Lymphoblastic Leukemia. A Pediatric Oncology Group Study. Leukemia and Lymphoma Vol 31, pp. 507-519, 1998. With M. Whitehead et. al.(6/17)


J. J. Shuster


Myeloperoxidase Gene Expression in Infant Leukemia: A Pediatric Oncology Group Study. Leukemia Vol. 29, pp. 145-159, 1998. With C. Alvarado et. al.

(4/9) Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate dose intravenous methotrexate and intrathecal triple therapy: A Pediatric Oncology Group Study. Journal of Clinical Oncology, Vol. 16, pp. 1712-1722, 1998. With D. Mahoney et. al. (2/7) Prognostic significance of gender in childhood B-precursor acute lymphoid leukemia: A Pediatric Oncology Group Study. J. Clinical Oncology, vol 16, pp. 2854-

2863, 1998. With P. Wacker et. al. (1/11) Consolidation with anti-metabolite based therapy in standard risk acute lymphocytic leukemia: A Pediatric Oncology Group Study. J. Clinical Oncology, vol. 16, pp.2840-2847, 1998. With M Harris et. al. (2/7) A Multi-disciplinary study investigating radiotherapy in Ewing’s Sarcoma-End results on POG #8346. J. RadiationOncology, Biology, and Physics, Vol. 42, pp. 125-135, 1998) With S. Donaldson et. al. (11/11) Heterogeneity of the t(11;19)(q23;p13) in childhood acute lymphoblastic leukemia: Favorable prognosis with T-cell phenotype. J. Clinical Oncology, vol. 17 (1), pp. 191-196, 1999. With J. Rubnitz et. al. (6/11) Treatment of localized primary non-Hodgkin's lymphoma of bone in children. . J. Clinical Oncology, vol. 17, pp. 456-459, 1999. (With K. Suryanarayan et. al.) (2/6) Second Report of the Cancer Therapy Evaluation Program (CTEP) Monitoring Plan for Secondary Leukemia or Myelodysplastic Syndrome Following Treatment with Epipodophyllotoxins" J. Clinical Oncology, Vol. 17, pp. 445-455, 1999. (With L. Rubinstein et. al. ) (12/13) Identification of Newly Diagnosed Children with Acute Lymphocytic Leukemia at High Risk for Relapse. Cancer Research Therapy and Control, Vol. 9, pp. 101-107, 1999. With B Camitta et. al. (1/9) Intensive high dose aspariginase improves survival for patients with T-Cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: Pediatric Oncology Group study 8704. Leukemia 13, pp. 335-342,1999. (With M. Amylon et. al.) (2/14) Lymph node sampling in localized neuroblastoma: A Pediatric Oncology Group study. Journal of Pediatric Surgery, 34(6), pp 967-974, 1999. (With M. Contador et. al. ) (4/6) Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWIST analysis of the Pediatric Oncology Group study 8821. Journal of Clinical Oncology, 17(7), pp. 2144-2152 ,1999. (With S Parsons, M. Chang et. al. (8/10)


J. J. Shuster


Oral Methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group Study J. of Pediatric Hematoplogy/Oncology, 22(1), pp 41-44, 2000. (With A. Mulne et. al. ) (7/8) Significance of commonly used prognostic factors differs for children with T cell acute lymphoblastic leukemia(ALL), as compared to those with B-Precursor ALL: A Pediatric Oncology Group Study. Leukemia 13, pp. 1696-1707, 1999. (With J. Pullen et. al.) (2/10) Glutathione S-tranferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia 14(2), pp. 232-237, 2000. (With M. Woo et. al.) (2/13) Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Leukemia 14, 14(3), pp 369-73, 2000. (with J. Laver et. al.) (12/12) Racial and ethnic differences in the survival of B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J. Clinical Oncology, 18(4), pp. 813-823,2000 (With B. Pollock et. al. (4/10) Intensification with intermediate dose intravenous methotrexate is effective for children with

lower risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Journal of Clinical Oncology, 18(6), pp 1285-94 2000 (with D. Mahoney et. al.) (2/6)

Acute lymphoblastic leukemia with an unusual t(8;14)(q12.2;q32): A Pediatric Oncology

Group Study. Leukemia 14(2), pp 238-240, 2000. (With Z. Kaleem et. al.) (2/9)

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med. 6;342(14), pp 998-1006, 2000. (With M. Arico et. al.) (19/22) Slow disappearance of peripheral blasts is an adverse prognostic factor in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Leukemia 14, pp 792-795, 2000. (With T Griffin et. al.) (2/6) The Prognostic Significance of Autologous Bone Marrow Transplant in Advanced Neuroblastoma (with A. Cantor et al). Classic Papers and Current Comments. 9, pp21- 25, 2000 (1/9). New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia. A Pediatric Oncology Group report of 343 cases. Blood, 96, 2543-2549, 2000. (With N. Schneider et. al.) (3/9) Treatment of children with early pre-B and Pre-B acute lymphoblastic leukemia with antimetabolite-based intensification regimens: A Pediatric Oncology Group

Study. Leukemia 14, pp. 1570-1576, 2000. (With M. Harris et. al.) (2/8) Long-term results of treatment studies in childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia 14, pp. 2276-2285, 2000. (With K

W Maloney . et. al.) (2/5)



The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia 15, 2001 (With M. Whitehead et. al) (6/11) A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating therapy for high risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Phase III randomized trial. Leukemia 15, pp. 1038-1045, 2001 (With S. Lauer et. al) (2/10) Effect of scleral expansion band on ocular hypertension: Canadian Phase I study. Annals of

Ophthalmology 33, pp. 290-297, 2001 (With A Rifkind et. al) (3/3)

Results of a randomized phase III trial in children and adolescents with advanced stage diffuse

large cell non Hodgkin's lymphoma: a Pediatric Oncology Group study. Leuk

Lymphoma, 43, pp 105-109, 2002 (With J. Laver et. al.) (10/10) Bone Marrow Stroma-supported culture of T-lineage acute lymphoblastic leukemia cells predicts treatment outcome in children: A Pediatric Oncology Group Study. Leukemia (16(6), pp 1121-1126, 2002 (With S Winter et. al) (3/8) Screening of infants and mortality due to neuroblastoma. New England Journal of Medicine, 346(14), pp 1041-1046, 2002 (With W. Woods et. al.) (3/12) Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements in the 11q23 chromosomal region. The Lancet, 359, pp 1909-1915, 2002 (With C. Pui et. al.) (20/24)

Implantation of scleral expansion band segments for the treatment of presbyopia. Am J

Ophthalmol. 2002 Dec;134(6):808-15. (with MA Qazi 2/3).

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23

rearrangements. Leukemia. 2003 Apr;17(4):700-6. (With C Pui 25/31)

Minimal residual disease detection in childhood precursor-B-cell acute

lymphoblastic leukemia: relation to other risk factors. A Children's Oncology

Group study. Leukemia. 2003 Aug;17(8):1566-72. (With M Borowitz 3/7)

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute

lymphoblastic leukemia are nonrandom and may be associated with outcome.

Leukemia, 2004 Apr;18(4):693-702. (with N. Hareema et. al. 20/24).

A Comparison of Red Blood Cell Thiopurine Metabolites in Children with Acute Lymphoblastic

Leukemia Who Received Oral Mercaptopurine Twice Daily or Once Daily: A Pediatric

Oncology Group Study. Pediatr Blood Cancer. 2004 Aug;43(2):105-109. (with B. Bell et. al.

3/7)


J. J. Shuster


Improving IVF Pregnancy Rates with a Manual Physical Therapy Technique.

Medscape 6(2) 2004 and MedGenMed. 2004 Jun 18;6(2):51. (With B. F. Wurn et. al 7/7)

Posted 6/18/2004 (13 Pages) http://www.medscape.com/viewarticle/480429_print

One-year Protocol Liver Biopsy Can Stratify Fibrosis Progression In Liver Transplant Recipients with Recurrent Hepatitis C Infection. Liver Transplant, 2004 Oct, 10(10), pp 1240-1247 ( with R.J. Firpi et. al. ) (5/11) Radial artery tonometry demonstrates arterial stiffness in children with type I diabetes. Diabetes

Care. 2004 Dec;27(12):2911-7. (With M.Haller et. al. ) (8/10) Diagnostic accuracy for lupus and other autoimmune diseases in the community setting. Arch Intern Med. 2004 Dec 13-27;164(22):2435-41 (With S Narain et. al.)(6/9)

The Effect of Propofol, a Sedative-Hypnotic Drug, on Thermal Pain. Anesthesia &

Anesth Analg. 2005 Feb;100(2):481-6. (With M. Froelich et. al.) (4/6)

.

Precision and bias of target controlled propofol infusion for sedation. Br J Anaesth. 2005 Jan

94(4): 434-437. (With M. Froelich et. al.) (3/4)

Assessment of cervical antibody concentrations fails to enhance the value of cervical length as a

predictor of preterm delivery. Am J Obstet Gynecol 2005; 192:887-91. (With R. Edwards

et. al.) (3/6)

Effects of the methylenetetrahydrofolate reductase 677CT polymorphism and dietary folate

restriction on plasma one carbon metabolites and red blood cell folate concentrations and

distribution in women. Journal of Nutrition 2005 May;135(5):1040-44. ( with G. Davis et. al.)

(11/13)

Homocysteine Synthesis Is Elevated but Total Remethylation Is Unchanged by the

Methylenetetrahydrofolate Reductase 677C->T Polymorphism and by Dietary Folate

Restriction in Young Women. Journal of Nutrition. 2005 May;135(5):1045-50. . ( with G.

Davis et. al.) (11/13)

Non-Prescription Epinephrine Inhaler During Nocturnal Asthma. Annals of Allergy, Asthma &

Immunology. 2005; Dec;95(6):530-4. [With L. Hendeles et. al.] ( 5/5)


http://www.medscape.com/viewarticle/480429_print

J. J. Shuster


High Concordance from Independent Studies by the Children’s Cancer Group (CCG) and

Pediatric Oncology Group (POG) Associating Favorable Prognosis with Combined Trisomies

4, 10, and 17 in Children with NCI Standard Risk B-precursor Acute Lymphoblastic

Leukemia: A Children’s Oncology Group (COG) Initiative. Leukemia 2005; May;19(5):734-

40. [With M Sutcliffe et. al.] (2/10)

The Gluten-Free, Casein-Free Diet In Autism: Results Of A Double Blind Clinical Trial.

Journal of Autism and Related Disorders, 2006; April 36 (3); 414-420 (With J Elder

et. al.) (3/6)

Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment

outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric

Oncology Group study. Leukemia, 2005 19 (Feb), 533-536 [With M. Whitehead et. al.](2/11)

High sensitivity C-Reactive Protein in systemic Lupus erythematosus: relation to disease

activity, clinical presentation and implications for cardiac risk. Lupus 2005;14(8):576-82..

[With EV Barnes et. al.] (4/10)

Total shoulder arthroplasty as an outpatient procedure using ambulatory perineural local

anesthetic infusion: a pilot feasibility study. Anesth Analg 2005; 101: 1319-22. [With B.

Ilfeld et. al] (5/8)

Effects of Growth Hormone on Sleep Abnormalities in Prader-Willi Syndrome, Journal

of Clinical Endocrinology and Metabolism, 2006; Feb;91(2):413-7 [with J. Miller et. al.]

(3/5)

Peripheral Neuropathy in Genetic Mitochondrial Diseases. Pediatric Neurology. 2006;

Feb;34(2):127-31. [With D. Stickler et. al.] (6/8).

Effectiveness of Nesiritide on Dialysis or All-Cause Mortality in Patients Undergoing

Cardiothoracic Surgery. Clinical Cardiology. 2006; Jan;29(1):18-24. with T. Beaver et. al.

(3/9)

Short-term atorvastatin treatment enhances specific antibody production following tetanus

toxoid vaccination in healthy volunteers. Vaccine. 2006 May 8;24(19):4035-40. With

PL Lee et. al. (6/10)

A controlled trial of dichloroacetate for treatment of congenital lactic acidosis in children.

Pediatrics. 2006 May;117(5):1519-31. With P. Stacpoole et. al. (16/19)

Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency.

Mitochondrion 2006; 240, JUN;6(3):126-35. with K Berendzen et. al. (3/4) .


J. J. Shuster


Ambulatory continuous interscalene nerve blocks decrease the time to discharge-readiness

following total shoulder arthroplasty: a randomized, triple-masked, placebo-controlled study.

Anesthesiology, 2006; 105, NOV(5): 999-1007, with B.M. Ilfeld et. al. (6/10)

Familial aggregation of insulin resistance in first degree relatives of patients with non-alcoholic

fatty liver disease. Clinical gastroenterology and Hepatology, 2006, Sep;4(9):1162-9. With M.

Abdelmalek et. al. (3/5)

Lung bioavailability of HFA Fluticasone in young children when delivered by anti-static

chamber/mask The Journal of Pediatrics, 2006; DEC 149; 793-797. With Y. Khan et. al. (4/7)

Adverse Impact of Temperature and Humidity on Blood Glucose Monitoring Reliability: A Pilot

Study. Diabetes Technology & Therapeutics 2007; 9(1), 1-9, with M. Haller et. al. (2/4) (Lead article)

Prediction of Intrauterine Pressure Waveform from Transabdominal Electrohysterography.

Journal of Maternal-Fetal & Neonatal Medicine, 2006; 19(12): 803–808. with T. Euliano

et. al. (3/4)

Peripheral artery tonometry demonstrates altered endothelial function in children with type I

Diabetes. Pediatric Diabetes. 2007 Aug;8(4):193-8. With M. Haller et. al. (3/8).

Pituitary Abnormalities in Prader-Willi Syndrome and Early-Onset Morbid Obesity. Am J Med

Genet A. 2008 Mar 1;146A(5):570-7. With J. Miller et. al. (4/8).

Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor

deficiency in Ecuador on IGF-I, IGFBP-3, and stature. Growth Hormone & IGF Research.

2007 Jun;17(3):261-4. with J. Guevara-Aguirre, A. Rosenbloom et. al. (7/7 )

Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute

lymphoblastic leukemia, Gene, Chromosomes and Cancer. 2007 Jul;46(7):684-93. With N.

Heerema et. al. (17/22).

Anti-metabolite therapy for lesser risk B-lineage acute lymphoblastic leukemia of childhood: a

report from Children's Oncology Group Study P9201, Blood. 2007 Aug 15;110(4):1105-11.

With AR. Chauvenet et. al. (10/11)

Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute

lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol. 2007

Sep;29(9):627-32. (With P. Wacker et. al) (6/6)


J. J. Shuster


Intensified PEG-L-asparaginase and Antimetabolite- Based Therapy for Treatment of Higher

Risk Precursor-B Acute Lymphoblastic Leukemia: A Report from the Children's Oncology

Group. J. Ped Hematology/Oncology, 2007 June, 29(6): 369-375, with W Salzer et.

al. (3 /8)

Biology-driven classification of childhood acute lymphoblastic leukemia: A combined analysis

of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer

Group (CCG). Blood 2007 Feb 1;109(3):926-35. With K.P Schultz et. al. (4/15).

Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate

vitamin B-12 status. Am J Clin Nutr. 2007 Apr;85(4):1057-61, with KM von Castel-Roberts

(6/9)

Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia.

Leukemia. 2007, Jun;21(6):1341-4. Apr 5; With SB Martin et. al. (19/22)

Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann

Pharmacother. 2007 Mar;41(3):381-90. With RC Hatton et. al. (4/5)

Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute

lymphoblastic leukemia: a Pediatric Oncology Group study. Cancer Genet Cytogenet. 2007

Jun;175(2):117-24. (With L Cooley et. al) (3/10)

Umbilical cord blood produces small megakaryocytes after transplantation. Biol Blood Marrow

Transplant. 2007 Feb;13(2):145-50. With M. Ignatz et. al (5/11)

Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J Pediatr.

2006 Aug;149(2):192-8. With J. Miller et. al (6/12)

Comparison of two dosimeters by methacholine challenge. J Allergy Clin Immun, 2007.

Nov;120(5):1218-9.14; With L. Hendeles et. al. (3/4)

Cardiac Safety of Central Nervous System Stimulants in Children and Adolescents with

Attention Deficit/Hyperactivity Disorder. Pediatrics 2007, Dec;120(6):1494-1501. (With A. Winterstein et. al) (3/5).

Peripheral artery tonometry demonstrates altered endothelial function in children with type I

Diabetes. Pediatric Diabetes. 2007; Aug; 8, pp 193-198, with M. Haller et. al. (3/9)

Sylvian fissure morphology in Prader-Willi syndrome and early-onset morbid obesity.

Genet Med. 2007 Aug;9(8):536-43. With J. Miller et. al. (6/9)

Evaluation of long-term treatment of children with congenital lactic acidosis with

dichloroacetate. Pediatrics 2008, May; 121(5): e1223-e1228.With P. Stacpoole et. al. (8/8)


http://www.ncbi.nlm.nih.gov/pubmed/17556067?ordinalpos=80&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum


J. J. Shuster


Ambulatory continuous femoral nerve blocks decrease time to discharge-readiness following

tricompartment total knee arthroplasty: a randomized, triple-masked, placebo-controlled study.

Anesthesiology 2008, April 108(4): 703-713. With B. Ilfeld et. al. (9/13).

Expression of CD44, but not CD44v6 predicts relapse in children with intermediate risk B cell

progenitor ALL. Leukemeia and Lymphoma 2008. Apr;49(4):710-8. With N. Khan et. al

(4/8).

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a

Children’s Oncology Group Study. J. Clinical Oncology 2008, May 1;26(13):2186-91.

With J Rubnitz et. al. (4/12)

The effects of varying local anesthetic concentration and dose on continuous popliteal sciatic

nerve blocks: a dual-center, randomized, observer-masked, controlled study. Anesth Analg,

2008, Aug;107 (2): 701-707. With B. Ilfeld et. al. (7/10)

Utilization of Pharmacologic Treatment in Youths with Attention Deficit/Hyperactivity Disorder

in Medicaid Database. The Annals of Pharmacotherapy 42(1), 2008, pp 24-31. (With A

Winterstein et. al. (3/7)

Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: A Children's

Oncology Group Study. Pediatric Blood & Cancer 2008, Jul; 51(1):29-33. With R

Hutchison et. al. (8 /9)

Atorvastatin in Diabetes Intervention Trial (PADIT-1): A Pilot Study to Determine the Effect of

Atorvastatin on Arterial Stiffness and Endothelial Function in Children with Type 1 Diabetes.

Journal of Pediatric Endocrinology and Metabolism. 2009;22(1):65-68. With M. Haller et. al.

(3/6)

Chest Compression Quality and Rescuer Fatigue with Increased Compression to Ventilation

Ratio during Single Rescuer Pediatric CPR Resuscitation. Resuscitation. 2008, Oct; 79(1):

82-89. With I. Haque et. al. (5/6).


J. J. Shuster


The rosigliazone meta-analysis: lessons for the future. Diabetes Care. 2008 Mar;31(3):e10. With

D. Schatz (1/2).

Effects of local anesthetic concentration and dose on continuous interscalene nerve blocks: a

dual-center, randomized, observer-masked, controlled study. Reg Anesth Pain Med, 2008,

Nov/Dec; 33(6), 518-525. With L Le (7/10)

Ambulatory continuous posterior lumbar plexus nerve blocks after hip arthroplasty: a

dual-center, randomized, triple-masked, placebo-controlled trial. Anesthesiology.

2008 Sep;109(3):491-501. With B. Ilfeld et. al. (10/12)

Hyperlidemia in glycogen storage disease type III: Effect of age and metabolic control. Journal

of Inherited Metabolic Disease 2008, Dec; 31(6): 729-732 (with A. Bernier et. al.) (5/7) .

Effect of Alternative Chest Compression Techniques in Infant and Child on Rescuer CPR

Performance. Pediatric Critical Care Medicine, 2009; 10(3):328-33. With J. Udassi et. al.

(4/6)

Use of Modified Cornstarch Therapy to Extend Fasting in Glycogen Storage Disease

Types Ia and Ib. The American Journal of Clinical Nutrition. 2008 Nov; 88(5): 1272-6

With C. Correia et. al. (4/8).

Vascular dysfunction in glycogen storage disease type IA. Journal of Pediatrics; 2009; 154(4);

588-91. With A. Bernier et. al. (5/6) (PMID=19101686)

Prospective Clinical Trial Comparing Outcome Measures Between Furlow and von Langenbeck

Palatoplasties for UCLP. Patient’s Physical Growth. The Cleft Palate-Craniofacial

Journal 2009, Nov;46(6):603-9. Epub 2009 May 16. PubMed PMID: 19860503.

with I. L. Marques (26/26)

Effects of local anesthetic concentration and dose on continuous infraclavicular nerve blocks: A

multi-center, randomized, observer-masked, controlled study. Anesth Analg, 2009;

108 (Jan): 345-350. With B. Ilfeld et. al. (9/13)

Health-related quality-of-life following tricompartment knee arthroplasty with and without an

extended- duration continuous femoral nerve block: a prospective, one-year follow-up of a

randomized, triple-masked, placebo-controlled study. Anesth Analg 2009; 108: 1320-5. With

B. Ilfeld et. al. (8/10)

Generation of CO2 from glycine carbons indicates high production of 1-carbon units from

glycine in healthy men and women. The Journal of Nutrition. 2009; 139(4): 666-671. ( with Y.

Lamers et. al.) (4/9)

Cardiac Safety of Methylphenidate versus Amphetamine Salts in the Treatment of Attention

Deficit/Hyperactivity Disorder. Pediatrics 2009; 124(1) e75-e80. With A Winterstein et. al. (3/5)


J. J. Shuster


Sleep-Disordered Breathing in Infants with Prader-Willi Syndrome During the First Six Weeks

of Growth Hormone Therapy: A Pilot Study. Journal of Clinical Sleep Medicine. 2009; 5(5):

448-453. with J. Miller et. al. (2/5)

Health-related quality-of-life following hip arthroplasty with and without an extended-duration

continuous posterior lumbar plexus nerve block: a prospective, 12-month follow-up of a

randomized, triple-masked, placebo-controlled study. Anesth Analg, 2009;109; 586-91. (With B.

Ilfeld et. al.) (10/12)

Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes.

Diabetes Care, 2009 Nov;32(11):2041-6. PubMed PMID: 19875605; PubMed Central PMCID:

PMC2768209. With M. Haller et. al. (9/11)

Improved chest recoil using an adhesive glove device for active compression-decompression

CPR in a pediatric manikin model. Resuscitation. Oct;80(10):1158-63. Epub 2009 Aug 15.

PubMed PMID: 19683849. With J. Udassi et. al. (6/8).

A plot study of Ocreotide LAR vs. Octreotide tid for pain and quality of life in chronic

pancreatitis. Journal of the Pancreas. 2009; 10(5) 518-522. With JG Lieb et. al. (2/6)

Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J.

Pediatrics 2010 Jan 156(1): 20-25.(E-Publication 9/25). With M. Mshvildadze et. al. (3/6) PMID

19783002.

Design and Statistical Analyses of Oral Medicine Studies: Common Pitfalls. Oral Diseases.

2010 April; 16(3); 233-241. With L. Baccaglini et. al. (2/7): PMCID 2879019 . (Awarded

best review article in Oral Diseases for 2010.)

A Longitudinal Description of Heart Rate Variability in 28-34-Week-Old Preterm Infants. Biol

Res Nurs. 2010 Jan; 11(3) 261-268 [Epub ahead of print] PubMed PMID: 19934110. With C.

Krueger et. al. (3/3)

Arterial Stiffness, Lipoprotein Particle Size and Lipoprotein Particle Concentration in Children

with Type 1 Diabetes. Journal of Pediatric Endocrinology and Metabolism. 2010 July; 23(7)

661-667. With L. Gallo et. al (3/4) PMID: 20857838

Two-thumb technique is superior to two-finger technique during lone rescuer

infant manikin CPR. Resuscitation. 2010 Jun;81(6):712-7 [Epub ahead of print] PubMed

PMID: 20227156. With S. Udassi et. al. (5/7)

A pilot study to evaluate atenolol exposure and risk for development of adverse metabolic

effects. Pharacotherapy. 2010, 30 (9), 872-878. With H. Navare et. al. (4/8) PMID: 20795842

** After 1989, (a/F9906

b)=a-th author of a total of b authors.



J. J. Shuster


A multicenter, randomized, triple-masked, placebo-controlled trial of the effect of ambulatory

continuous femoral nerve blocks on discharge-readiness and analgesia following total knee

arthroplasty in patients on general orthopaedic wards. PAIN 2010;150: 477-484. . With B. Ilfeld

et. al. (10/12)

Carnitine and coenzyme Q10 levels in individuals with Prader-Willi syndrome. Am J Med Genet

2011 Feb 18. [Epub ahead of print] PubMed PMID: 21337696. (With J. Miller et. al. ) (3/4)

Augmented therapy improves outcome for pediatric high risk acute lymphocytic

leukemia: Results of Children's Oncology Group trial P9906. Pediatr Blood Cancer.

2011 Oct;57(4):569-77 PubMed PMID: 21360654. PMCID 3136564 (With WP Bowman et. al)

(9/14)

Otologic and Audiologic Outcomes with the Furlow and Von Langenbeck with Intravelar

Veloplasty Palotoplasties in Unilateral Cleft Lip and Palate. The Cleft Palate-Craniofacial

Journal 2011, Jul;48(4):412-8. PMID: 20536371. (with P. Antonelli et. al.) (19/23)

Prospective Clinical Trial Comparing Outcome Measures Between Furlow and von

Langenbeck Palatoplasties for UCLP. 2010. Annals of Plastic Surgery I2011; 66(2):154-

163. with W. Williams et. al. (13/31) PMID 21042188

Trends in Thoracic Aneurysm Repair in The United States. To appear in Annals of Thoracic

Surgery 2010. Dec;90(6):1833-9. PubMed PMID: 21095320. With K.L. Walker et. al. (2/3)

A Pilot Study of Novel biomarkers in neonates with Hypoxic-Ischemic

Encephalopathy.Pediatric Research, EPUB ahead of Print. PMID 20736881 8/2010. With M.

Douglas-Escobar (4/11).

Long-Term Pain, Stiffness, and Functional Disability Following Total Knee Arthroplasty With

and Without an Extended Ambulatory Continuous Femoral Nerve Block: A Prospective, One-

Year Follow-Up of a Multicenter, Randomized, Triple-Masked, Placebo-Controlled Trial. To

appear in Regional Anesthesia and Pain Medicine , 2011; 36(2) March, 116-120. PubMed

PMID: 21425510; PubMed Central PMCID: PMC3073537. With B. Ilfeld et. all. (2/12).

Use of Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β-

antagoinist. Pharmacotherapy 2011;31(5): 449-457. With S. Prabhakaran et. al. (2/4)

Plasma Methotrexate, Red Blood Cell Methotrexate and Red Blood Cell Folate Values and

Outcome in Children with Precursor B Acute Lymphoblastic Leukemia. Journal of Pediatric


J. J. Shuster

Hematology/Oncology 2011. [Epub ahead of print] PubMed PMID: 21364468. (with W. Salzer

et. al.) (6/9)

Nonadministration of routine probiotics unethical--really? Pediatrics. 2010 Sep;126(3):e740-1;

PubMed PMID: 20810713. (With J. Neu) )( 2/2)

Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels:

prediction of acute rejection versus viral replication events, Pediatric Transplantation 2011.

May;15(3):321-8. PubMed PMID: 21492353; PubMed Central PMCID: PMC3078420.

(with V. Dhanrnidharka et. al) (5/8)

Nutritional Phases in Prader-Willi Syndrome. American Journal of Medical Genetics – part A,

2011 May;155A(5):1040-9. PubMed PMID: 21465655. (With J. Miller, et. al) (8/9)

Control in the Middle (CIM) for Three-arm Crossover Studies. Planta Medica. 2011 Sept; 77:

1473-1476 PubMed PMID: 21509714 with S. Anton et. al. (1/4)

Systemic Exposure to Fluticasone MDI Delivered through Anti-Static Chambers. Journal of Allergy and Clinical Immunology. 2011 [Epub ahead of print] PubMed PMID: 21783234. (with M. ElMallah et. al.) (4/5)

Investigations of botanicals on food intake, satiety, weight loss, and oxidative stress: a study

protocol of a double-blind, placebo-controlled, crossover study. Journal of Chinese Integrative

Medicine. 2011 Nov;9(11):1190-8., with S. Anton (2/3).

Outcomes of Late Corticosteroid Withdrawal After Renal Transplantation in Patients Exposed to

Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials.

Pharmacotherapy 2011; 2(4): 149-159. With AK. Ali et. al. (4/4)

Autologous Umbilical Cord Blood Transfusion in Young Children with Type 1 Diabetes Fails to

Preserve C-Peptide. Diabetes Care. To appear 2011. With M. Haller et. Al. (10/12)

The Spectrum of Pyruvate Dehydrogenase Complex Deficiency: Clinical, Biochemical and

Genetic Features in 371 Patients. Molecular Genetics and Metabolism 2012,105(1); 34-43. With

K. Patel et. al. (4/5).

J. J. Shuster SELECTED OTHER PUBLICATIONS:

The Validation of a Petition by a Sample Survey. Proceedings of the American Statistical Association, Social Statistics Section (1974).

Practical Permutation Tests in Complex Experimental Design. Proceedings of the

American Statistical Association, Statistical Computing Section (1978).

Randomized Tests for an In Vitro Assay of Antibiotics. Randomization vol. 1, Number 4 (1979).

Deja Vu. Randomization, Volume 2, Number 1 (Reviews Permutation Tests Applied to

Antibiotic Drug Resistance, JASA vol. 69, 1979, pp 87-92 (1974)). Statistical Office Concerns in Selection of a Data Management System. Workshop on the

Role of Computers in Clinical Cancer Trials (NIH Publication 83-2627) pp 143-144 (1983) (B. Edwards Editor). Letter to the Editor (Refereed) (with L. Frankel, et al). Journal of Clinical Oncology vol.

2, 1984, pp 1072.

Adjuvant Chemotherapy of Osteosarcoma of the Extremity: Results of the Multi-Institutional Osteosarcoma Study (with M. P. Link, et al). Proceedings of the First International Symposium on Sarcomas (1987).

The Non-Hodgkin’s Lymphomas in Adolescents (with E. Hvizdala, et al). Major Topics Adolescent Oncology (edited by Cameron Tebbi) (1987).

Results and Lessons for the Future from the Pediatric Oncology Group Studies (8104-8441) from the Surgical Viewpoint (with E. Smith et al) Transaction of the Japanese Society of Pediatric Oncology vol. 25, 1988, pp 71-80.

Adjuvant Chemotherapy in the Treatment of Osteosarcoma: Results of the Multi-Institutional Osteosarcoma Study (with M. Link et al). In: Recent Concepts in Sarcoma Treatment. Proceedings of the International Symposium on Sarcomas, Tarpon Springs, Florida, October 8-10, 1987. J Ryan and LH Baker, eds. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1988, pp 283-290.

Should Inferences From Observational Study of Treatment Results be Applied in

Osteosarcoma? (editorial) Journal of the National Cancer Institute vol. 81, 1989, pp 2-3.

Conditional vs Unconditional Tests in 2x2 Trials (with S. Suissa). Proceedings of the Biopharmaceutical Section, American Statistician Association, 20-24 (1990).

Median Follow-up in Clinical Trials. Journal of Clinical Oncology (Refereed Letter) vol. 9, 1991, pp 191-192.

Surgico-Pathologic Staging of Neuroblastoma (with R. Castleberry et al). Journal of Clinical Oncology (Refereed letter) vol. 9, 1991, pp 189.

Results and Lessons for the Future from the Pediatric Oncology Group Studies (8104, 8441) from the Surgical Viewpoint (Chapter in Pediatric Oncology, 25th edition) (with E. Smith et al). (1991)

J. J. Shuster

SELECTED OTHER PUBLICATIONS: (Continued)

Pui CH, Carroll LAJ, Raimondi SC, Shuster JJ, Crist WM, Pullen DJ. Childhood acute

lymphoblastic leukemia with the t(4;11)(q21;q23): an update [letter]. Blood

1994 Apr 15;83(8):2384-5.

Cantor AB, Shuster JJ, Re: Dangers of using optimal cutpoints in the evaluation of

prognostic factors. Comment on: Journal National Cancer Institute 1994

Jun 1;86(11):829-35. J Natl Cancer Inst 1994 Dec 7;86(23):1798-9.

Re Weirsman Clinical Significance of Myeloid Antigen Expression in Pediatric Acute Lymphocytic Leukemia (with M. Borowitz et al) New England Journal of Medicine. (1992)

Interpretation of Nonsignificant Results (Shuster, J.J.). Journal of Clinical Oncology (letter) vol. 10, 1992, pp 1370-1371.

Screening for Neuroblastoma (NB) in North America: The Quebec Project (with W. Woods et al) 6th Symposium on Neuroblastoma Research.

Towards A More Uniform Approach To Risk-Classification And Treatment Assignment

For Children With Acute Lymphoblastic Leukemia. ASCO Educational Book, 30th Annual Meeting, pp. 124-130, 1995 (with M. Smith et al) (16/21)

Radiation in Pediatric Hodgkin’s Disease. Journal of Clinical Oncology (refereed letter)

vol. 16, p. 393, 1998. (With P. Gieser) (1/2) FREE STATISTICAL CONSULTING SOFTWARE written by J. J. Shuster: http://www.ehpr.ufl.edu/?q=node/100 These widely used programs are user friendly, well documented SAS macros, with

worked numerical examples and can be downloaded from the above website. These programs can also be obtained from the Clinical and Translational Statistician Website: http://ags.bwh.harvard.edu/

PROFESSIONAL WEBSITE: http://www.ehpr.ufl.edu/shuster

http://www.ehpr.ufl.edu/?q=node/100

http://ags.bwh.harvard.edu/

http://www.ehpr.ufl.edu/shuster

October 10, 2012 RESUME NAME: Shuster, Jonathan J. BORN ... · (2/3) (with M. Chang and J Kepner)....

Documents

Transcript of October 10, 2012 RESUME NAME: Shuster, Jonathan J. BORN ... · (2/3) (with M. Chang and J Kepner)....